Hartland & Co »

Galectin Therapeutics shares owned by Hartland & Co

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Hartland & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.0k 3.0k 1.66
2023-09-30 $5.8k 3.0k 1.92
2023-06-30 $2.2k 1.5k 1.44

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Small Cp Etf (VB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr Ser Tr S&p Divid Etf (SDY)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Russell 3000 Etf (IWV)

View all positions for Hartland & Co

Top funds holding Galectin Therapeutics

Vanguard Group
Advisor Group Holdings
Geneos Wealth Management
Atria Wealth Solutions
Sontag Advisory
Cambridge Investment Research Advisors
Commonwealth Equity Services
Cutter & CO Brokerage
683 Capital Management
Horizon Kinetics Asset Management
D.A. Davidson & Co.
Stratos Wealth Partners
William Blair $ Company
Independent Advisor Alliance
Solutions 4 Wealth

View all funds holding Galectin Therapeutics